Literature DB >> 34746493

Buprenorphine for Chronic Pain: A Safer Alternative to Traditional Opioids.

Suhani Dalal1, Ahish Chitneni1, Amnon A Berger2, Vwaire Orhurhu3, Bilal Dar4, Bennett Kramer5, Anvinh Nguyen6, John Pruit6, Charles Halsted6, Alan D Kaye7, Jamal Hasoon8.   

Abstract

With the ongoing public health crisis with prescription opioids, there is a need for safer alternatives for medication management in chronic pain patients. Buprenorphine is a partial mu-opioid agonist which is commonly utilized to treat patients with opioid-use disorders. The purpose of this review is to discuss the potential use of this medication for the treatment of chronic pain instead of resorting to more traditional Schedule II opioids. Buprenorphine offers a safer alternative for patients who require opioids to manage chronic pain, given the unique pharmacological properties that allow it to provide adequate analgesia with less abuse potential.

Entities:  

Keywords:  analgesics; buprenorphine; chronic pain; opioids

Year:  2021        PMID: 34746493      PMCID: PMC8567798          DOI: 10.52965/001c.27241

Source DB:  PubMed          Journal:  Health Psychol Res        ISSN: 2420-8124


  43 in total

1.  Effects of intermittent hemodialysis on buprenorphine and norbuprenorphine plasma concentrations in chronic pain patients treated with transdermal buprenorphine.

Authors:  Jörg Filitz; Norbert Griessinger; Reinhard Sittl; Rudi Likar; Jürgen Schüttler; Wolfgang Koppert
Journal:  Eur J Pain       Date:  2006-01-19       Impact factor: 3.931

2.  WHO guidelines for the use of analgesics in cancer pain.

Authors:  V Ventafridda; L Saita; C Ripamonti; F De Conno
Journal:  Int J Tissue React       Date:  1985

3.  Effect of buprenorphine and antiretroviral agents on the QT interval in opioid-dependent patients.

Authors:  Jennifer R Baker; Al M Best; Patricia A Pade; Elinore F McCance-Katz
Journal:  Ann Pharmacother       Date:  2006-02-28       Impact factor: 3.154

Review 4.  Treating Chronic Pain: An Overview of Clinical Studies Centered on the Buprenorphine Option.

Authors:  Mellar P Davis; Gavril Pasternak; Bertrand Behm
Journal:  Drugs       Date:  2018-08       Impact factor: 9.546

Review 5.  Mu opioid receptors in pain management.

Authors:  Gavril Pasternak; Ying-Xian Pan
Journal:  Acta Anaesthesiol Taiwan       Date:  2011-03-17

6.  Transdermal buprenorphine plus oral paracetamol vs an oral codeine-paracetamol combination for osteoarthritis of hip and/or knee: a randomised trial.

Authors:  P G Conaghan; C M O'Brien; M Wilson; J P Schofield
Journal:  Osteoarthritis Cartilage       Date:  2011-04-06       Impact factor: 6.576

7.  Opioids and the management of chronic severe pain in the elderly: consensus statement of an International Expert Panel with focus on the six clinically most often used World Health Organization Step III opioids (buprenorphine, fentanyl, hydromorphone, methadone, morphine, oxycodone).

Authors:  Joseph Pergolizzi; Rainer H Böger; Keith Budd; Albert Dahan; Serdar Erdine; Guy Hans; Hans-Georg Kress; Richard Langford; Rudolf Likar; Robert B Raffa; Paola Sacerdote
Journal:  Pain Pract       Date:  2008-05-23       Impact factor: 3.183

8.  Buprenorphine for Chronic Pain: a Systemic Review.

Authors:  Michael A Fishman; Phillip S Kim
Journal:  Curr Pain Headache Rep       Date:  2018-10-05

9.  Pharmacokinetics of transdermal buprenorphine patch in the elderly.

Authors:  Nabil Al-Tawil; Ingegerd Odar-Cederlöf; Anna-Carin Berggren; Helen E Johnson; Jan Persson
Journal:  Eur J Clin Pharmacol       Date:  2012-06-17       Impact factor: 2.953

10.  Effectiveness and tolerability of transdermal buprenorphine patches: a multicenter, prospective, open-label study in Asian patients with moderate to severe chronic musculoskeletal pain.

Authors:  Do Heum Yoon; Seong-Il Bin; Simon Kin-Cheong Chan; Chun Kee Chung; Yong In; Hyoungmin Kim; Juan Javier Lichauco; Chi Chiu Mok; Young-Wan Moon; Tony Kwun-Tung Ng; Ester Gonzales Penserga; Dong Ah Shin; Dora You; Hanlim Moon
Journal:  BMC Musculoskelet Disord       Date:  2017-08-04       Impact factor: 2.362

View more
  4 in total

1.  A Look at Commonly Utilized Serotonin Noradrenaline Reuptake Inhibitors (SNRIs) in Chronic Pain.

Authors:  Christopher Robinson; Suhani Dalal; Ahish Chitneni; Anand Patil; Amnon A Berger; Syed Mahmood; Vwaire Orhurhu; Alan D Kaye; Jamal Hasoon
Journal:  Health Psychol Res       Date:  2022-05-30

2.  Buprenorphine and its formulations: a comprehensive review.

Authors:  Salomon Poliwoda; Nazir Noor; Jack S Jenkins; Cain W Stark; Mattie Steib; Jamal Hasoon; Giustino Varrassi; Ivan Urits; Omar Viswanath; Adam M Kaye; Alan D Kaye
Journal:  Health Psychol Res       Date:  2022-08-20

3.  Pain Management and Telemedicine: A Look at the COVID Experience and Beyond.

Authors:  Jamal Hasoon; Ivan Urits; Omar Viswanath; Alan D Kaye
Journal:  Health Psychol Res       Date:  2022-09-04

Review 4.  Current and Future Therapeutic Options in Pain Management: Multi-mechanistic Opioids Involving Both MOR and NOP Receptor Activation.

Authors:  Flaminia Coluzzi; Laura Rullo; Maria Sole Scerpa; Loredana Maria Losapio; Monica Rocco; Domenico Billeci; Sanzio Candeletti; Patrizia Romualdi
Journal:  CNS Drugs       Date:  2022-05-26       Impact factor: 6.497

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.